These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4084666)

  • 1. Oral and rectal nalbuphine bioavailability: first-pass metabolism in rats and dogs.
    Aungst BJ; Lam G; Shefter E
    Biopharm Drug Dispos; 1985; 6(4):413-21. PubMed ID: 4084666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Species variation in the disposition of nalbuphine and its acetylsalicylate ester analogue.
    Harrelson JC; Wong YJ
    Xenobiotica; 1988 Nov; 18(11):1239-47. PubMed ID: 3245223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The disposition and bioavailability of intravenous and oral nalbuphine in healthy volunteers.
    Lo MW; Schary WL; Whitney CC
    J Clin Pharmacol; 1987 Nov; 27(11):866-73. PubMed ID: 3429694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buccal and oral bioavailability of nalbuphine in rats.
    Hussain MA; Aungst BJ; Shefter E
    J Pharm Sci; 1986 Feb; 75(2):218-9. PubMed ID: 3958937
    [No Abstract]   [Full Text] [Related]  

  • 5. Rectal absorption of nitroglycerin in the rat: avoidance of first-pass metabolism as a function of rectal length exposure.
    Kamiya A; Ogata H; Fung HL
    J Pharm Sci; 1982 Jun; 71(6):621-4. PubMed ID: 6808113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Morphine hydrochloride suppositories. II. Bioavailability of morphine hydrochloride suppositories in dogs].
    Tan T; Kitamura K; Yamanaka M; Kojima K; Nakanishi Y; Arakawa S
    Yakugaku Zasshi; 1990 Jun; 110(6):434-41. PubMed ID: 2213530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of rectal absorption of insulin using salicylates in dogs.
    Nishihata T; Rytting JH; Kamada A; Higuchi T; Routh M; Caldwell L
    J Pharm Pharmacol; 1983 Mar; 35(3):148-51. PubMed ID: 6132970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of salicylate and other enhancers on rectal absorption of erythropoietin in rats.
    Mizuno A; Ueda M; Kawanishi G
    J Pharm Pharmacol; 1992 Jul; 44(7):570-3. PubMed ID: 1357136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of nalbuphine in infants, young healthy volunteers, and elderly patients.
    Jaillon P; Gardin ME; Lecocq B; Richard MO; Meignan S; Blondel Y; Grippat JC; Bergnieres J; Vergnoux O
    Clin Pharmacol Ther; 1989 Aug; 46(2):226-33. PubMed ID: 2758732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacokinetics of oral and intravenous nalbuphine in healthy volunteers.
    Aitkenhead AR; Lin ES; Achola KJ
    Br J Clin Pharmacol; 1988 Feb; 25(2):264-8. PubMed ID: 3358889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biopharmaceutical evaluation of ketoprofen following intravenous, oral, and rectal administration in dogs.
    Schmitt M; Guentert TW
    J Pharm Sci; 1990 Jul; 79(7):614-6. PubMed ID: 2398469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
    Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-pass elimination of lidocaine in the rabbit after peroral and rectal route of administration.
    Ritschel WA; Elconin H; Alcorn GJ; Denson DD
    Biopharm Drug Dispos; 1985; 6(3):281-90. PubMed ID: 4041555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased bioavailability of propranolol in rats by retaining thermally gelling liquid suppositories in the rectum.
    Ryu JM; Chung SJ; Lee MH; Kim CK; ShimCK
    J Control Release; 1999 May; 59(2):163-72. PubMed ID: 10332051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Avoidance of "first-pass" elimination of rectally administered lidocaine in relation to the site of absorption in rats.
    de Leede LG; de Boer AG; Roozen CP; Breimer DD
    J Pharmacol Exp Ther; 1983 Apr; 225(1):181-5. PubMed ID: 6834271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the bioavailability of oral, rectal and intramuscular promethazine.
    Schwinghammer TL; Juhl RP; Dittert LW; Melethil SK; Kroboth FJ; Chung VS
    Biopharm Drug Dispos; 1984; 5(2):185-94. PubMed ID: 6743785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rectal bioavailability of lidocaine in man: partial avoidance of "first-pass" metabolism.
    de Boer AG; Breimer DD; Mattie H; Pronk J; Gubbens-Stibbe JM
    Clin Pharmacol Ther; 1979 Dec; 26(6):701-9. PubMed ID: 498711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of nalbuphine in patients undergoing general anaesthesia.
    Sear JW; Keegan M; Kay B
    Br J Anaesth; 1987 May; 59(5):572-5. PubMed ID: 3580238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Morphine hydrochloride suppositories. I. Bioavailability of morphine hydrochloride suppositories in rats].
    Tan T; Kojima K; Nakanishi Y; Arakawa S
    Yakugaku Zasshi; 1990 Jun; 110(6):426-33. PubMed ID: 2213529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased bioavailability of tacrolimus after rectal administration in rats.
    Sakai M; Hobara N; Hokama N; Kameya H; Ohshiro S; Sakanashi M; Saitoh H
    Biol Pharm Bull; 2004 Sep; 27(9):1480-2. PubMed ID: 15340245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.